In estrogen receptor-negative breast cancer, dual inhibition of inducible nitric oxide synthase (iNOS) and COX-2 significantly reduced tumor volume in xenograft murine models, suggesting possible benefit from dual targeting of these enzymes [45]. Here, ESR1 is linked to neoplasm.